The REACT-2 study from Imperial College London aims to estimate the prevalence of SARS-CoV-2 antibodies across England.
This round has self-testing finger prick antibody test results from over 207,000 people, taken between 12 and 25 May 2021.
The pre-print details findings from vaccinated and unvaccinated people, and also different social and demographic groups.
Journalists dialled in to this briefing to hear from the scientists about their study. Please note this data is a preprint, so it is early work that has not yet been through peer-review and is not published in a journal.
Prof Paul Elliott, Director of the REACT programme, and Chair in Epidemiology and Public Health Medicine, Imperial College London
Prof Helen Ward, Professor of Public Health, Imperial College London
Prof Graham Cooke, Professor of Infectious Diseases, Imperial College London
This Briefing was accompanied by an SMC Roundup of Comments.